Hypoxia-targeted radiotherapy dose painting for head and neck cancer using ¹⁸F-FMISO PET: A biological modeling study

References

• Joiner MC, Van der Kogel AJ, editors. Basic clinical radiobiology. 4th ed. London: Hodder Arnold; 2009.
   Google Scholar
• Janssen HL, Haustermans KM, Balm AJ, Begg AC. Hypoxia in head and neck cancer: How much, how important?. Head Neck 2005;27:622–38.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis. Radiother Oncol 2011;100:22–32.
   PubMed Web of Science ®Google Scholar
• Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:312–21.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity- modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000;46:1117–26.
   PubMed Web of Science ®Google Scholar
• Zimny M, Gagel B, DiMartino E, Hamacher K, Coenen HH, Westhofen M, et al. FDG – a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2- polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging 2006;33:1426–31.
   PubMed Web of Science ®Google Scholar
• Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med 2007;37:451–61.
   PubMed Web of Science ®Google Scholar
• Popple RA, Ove R, Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 2002;54:921–7.
   PubMed Web of Science ®Google Scholar
• Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 2006;47:410–8.
   PubMed Web of Science ®Google Scholar
• Lee N. A phase II study of concurrent chemoradiotherapy using three-dimensional conformal radiotherapy (3D- CRT) or intensity-modulated radiation therapy (IMRT) + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. RTOG 0615 [Internet]. 2011 [updated 2011 Feb 16; cited 2012 Jun 20]. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0615.
   Google Scholar
• Sanchez-Nieto B, Nahum AE. BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans. Med Dosim 2000;25:71–6.
   PubMedGoogle Scholar
• Avanzo M, Stancanello J, Franchin G, Sartor G, Jena R, Drigo A, et al. Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy. Med Phys 2010;37:1533–44.
   PubMed Web of Science ®Google Scholar
• Fowler JF. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 2007;68:1491–5). Int J Radiat Oncol Biol Phys 2008;71:326–9.
   PubMedGoogle Scholar
• Carlson DJ, Stewart RD, Semenenko VA. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys 2006;33:3105–15.
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123–35.
   PubMed Web of Science ®Google Scholar
• Semenenko VA, Li XA. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol 2008;53:737–55.
   PubMed Web of Science ®Google Scholar
• Agren A, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990;19:1077–85.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: A planning study. Int J Radiat Oncol Biol Phys 2007;68:291–300.
   PubMed Web of Science ®Google Scholar
• Hendrickson K, Phillips M, Smith W, Peterson L, Krohn K, Rajendran J. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. Radiother Oncol 2011;101:369–75.
   PubMed Web of Science ®Google Scholar
• Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008;70:1219–28.
   PubMed Web of Science ®Google Scholar
• Eschmann SM, Paulsen F, Bedeshem C, Machulla HJ, Hehr T, Bamberg M, et al. Hypoxia-imaging with (18)F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol 2007;83: 406–10.
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, Coghe M, Madani I. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011;80:1045–55.
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007;68:126–35.
   PubMed Web of Science ®Google Scholar